Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kovarik JM et al. – The strong CYP3A4 inhibitor ketoconazole increased sotrastaurin AUC by 4.6–fold. A compensatory reduction in the dose of sotrastaurin is warranted when strong CYP3A4 inhibitors are co–administered.

Related Articles

Phase II Study of Androgen Synthesis Inhibition with Ketoconazole, Hydrocortisone, and Dutasteride in Asymptomatic Castration-Resistant Prostate Cancer
Clinical Cancer Research, 11/09/09    Relevance Score: 87%

Activity of ketoconazole after taxane-based chemotherapy in castration-resistant prostate cancer
BJU International, 11/02/09    Relevance Score: 83%

Paracoccidioidomycosis
Paediatric Respiratory Reviews, 11/10/09    Relevance Score: 80%

Antifungal activity of the aqueous extract of Ilex paraguariensis against Malassezia furfur
Phytotherapy Research, 10/14/09    Relevance Score: 77%

Fesoterodine: a new antimuscarinic for overactive bladder
Aging Health, 10/13/09    Relevance Score: 77%

Today in Basic Science...keeping you current

A Conserved Motif in the Membrane Proximal C-Terminal Tail of Human Muscarinic M1 Acetylcholine Receptors Affects Plasma Membrane Expression
Journal of Pharmacology and Experimental Therapeutics, 11/25/09

The Basic Helix-loop-helix Proteins DEC1 and DEC2 Function as Corepressors of Retinoid X Receptors
Molecular Pharmacology, 11/25/09

Control of GluR2 translational initiation by its alternative 3'UTRs
Molecular Pharmacology, 11/25/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address